Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nutrition 21, XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes - Nutraceuticals World

What are you searching for?

Sign in
Research

Nutrition 21, XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Nutrition 21, Inc., and XL Health Corporation have released positive results from a randomized, double-blinded, placebo-controlled clinical trial evaluating the effects of Diachrome, a combination of chromium picolinate and biotin, on glycated hemoglobin (HbA1c), fasting plasma glucose, cholesterol and triglyceride profiles in patients with type 2 diabetes. The 453-patient multi-center trial was conducted by Nutrition 21 in collaboration with XL Health, a nationally recognized disease management firm managing chronically ill patients for the Centers for Medicare and Medicaid Services (CMS) and private Medicare Advantage markets. It is the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters